
Roche Launches $100M Cancer Immunotherapy R&D Network
Roche said today it will launch a CHF 100 million ($100.1 million) global network of 21 academic centers focused on cancer immunotherapy R&D. The new
Roche said today it will launch a CHF 100 million ($100.1 million) global network of 21 academic centers focused on cancer immunotherapy R&D. The new
Roche said today it will launch a CHF 100 million ($100.1 million) global network of 21 academic centers focused on cancer immunotherapy R&D. The new
Transcription factors have long been viewed as “undruggable” targets for therapy: however, this concept may now need some tweaking. Cho et al. found that a
Over the years vitamin C supplementation has had a tumultuous relationship with empirical science. In 1753, James Lind, a Scottish surgeon with the British Royal
Vice President Joe Biden, in describing the cancer research initiative President Obama asked him to lead, said “the goal of this initiative—this ‘moonshot’ is to
The hottest technique in gene editing, called CRISPR, could soon be used to study human embryos. On 14 January, a regulatory committee in the United
Merck & Co. said this afternoon it has acquired IOmet Pharma, a small-molecule drug developer focused on cancer immunotherapy and cancer metabolism, for an undisclosed
Merck & Co. said this afternoon it has acquired IOmet Pharma, a small-molecule drug developer focused on cancer immunotherapy and cancer metabolism, for an undisclosed
A well-powered clinical trial that failed to replicate promising results in animal models of fragile X syndrome yields important lessons for clinical trial design (Berry-Kravis
It sounds paradoxical, but chimeric antigen receptor (CAR) T cells can be more easy-going and more effective at killing cancer cells. Engineering a lackadaisical but
Chinese stem-cell scientists have welcomed long-awaited measures that, state media claim, will rein in rogue use of stem cells in clinics while allowing research. The
Broadly neutralizing antibodies, those that could squash a wide swath of virus types, are the supreme goal of HIV vaccine development. Although some people infected
Created by ePubSystems. Contact Us for similar site for your university or institute.